Literature DB >> 8142150

Treatment of relapse of breast cancer after adjuvant systemic therapy--review and guidelines for future research.

R D Rubens1, E Bajetta, J Bonneterre, J G Klijn, P E Lønning, R Paridaens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8142150     DOI： 10.1016/s0959-8049(05)80029-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  4 in total

Review 1.  Breast cancer (metastatic).

Authors:  Justin Stebbing; Sarah Ngan
Journal:  BMJ Clin Evid       Date:  2010-09-08

Review 2.  Epirubicin. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of breast cancer.

Authors:  A J Coukell; D Faulds
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

Review 3.  Breast cancer (metastatic).

Authors:  Justin Stebbing; Sarah Slater; Maurice Slevin
Journal:  BMJ Clin Evid       Date:  2007-02-01

4.  Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer.

Authors:  J A Foekens; H Portengen; M P Look; W L van Putten; B Thirion; M Bontenbal; J G Klijn
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.